Orphan-drug designations in the US increased from 208 during 2000 to 2002, to 425 in 2006 to 2008

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.596, 2010-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EU orphan drug designations

By  

Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

US orphan drug designation granted for MGCD0103

By  

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

STX 100 receives orphan drug designation in the US.

By  

Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Developments in hepatitis C therapy during 2000 – 2002

By Poordad F Fred   Tran Tram   Martin Paul  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 9-25

Informa Healthcare

Access to resources Recommend Favorite

US FDA grants orphan drug designation for imisopasem manganese

By  

Inpharma, Vol. 1, Iss. 1629, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite